ARVO Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, S.D.
Right arrow Articles by Lowder, C.Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Smith, S.D.
Right arrow Articles by Lowder, C.Y.
Invest Ophthalmol Vis Sci 2004;45: E-Abstract 2682.
© 2004 ARVO


2682—B317

Trabeculectomy in Children with Juvenile Idiopathic Arthritis (JIA)–Associated Uveitic Glaucoma

S.D. Smith, L.A. Lam and C.Y. Lowder

Ophthalmology, Cleveland Clinic Cole Eye Institute, Cleveland, OH

Commercial Relationships: S.D. Smith, None; L.A. Lam, None; C.Y. Lowder, None.

Grant Identification: none

Abstract

Purpose: To describe outcomes of trabeculectomy with anti–metabolites in children with Juvenile Idiopathic Arthritis (JIA)–associated uveitis.

Methods: Retrospective review of patients 14 years or younger with JIA–associated uveitic glaucoma who underwent trabeculectomy with or without phacoemulsification cataract surgery with posterior chamber intraocular lens implantation (CE/PC–IOL) between January 1996 and June 2002. Patients underwent trabeculectomy when the intraocular pressure (IOP) was greater than 28 mm Hg on maximal medical therapy and cataract surgery when the best corrected vision was 20/100 or less.

Results: Eight children (7 female, 1 male) with a median age of 10 years at the time of surgery were included in this study. Ten eyes underwent trabeculectomy with anti–metabolite (2 children had bilateral surgery and 3 eyes had CE/PC–IOL at the time of trabeculectomy surgery). Median duration of uveitis before glaucoma surgery was 3.1 years. Seven of eight children were on systemic immunosuppression for an average of 2.4 years before surgery. All patients received intensive and prolonged post–operative topical corticosteroid and immunosuppressive therapy. Seven of 10 eyes had surgical success; five of 10 eyes had complete success defined as IOP<22 mm Hg without medications. Three eyes failed (failure is defined as IOP>21 mm Hg with topical medications). Pre–operative median IOP was 34 mm Hg compared to the post–operative median IOP of 15.5 mm. All 3 eyes that underwent combined trabeculectomy and CE/PC–IOL had final vision > 20/25.

Conclusions: Trabeculectomy surgery can be successful in patients with JIA–associated uveitis with appropriate patient selection and adequate pre– and post–operative control of inflammation.

Keywords: clinical (human) or epidemiologic studies: outcomes/complications • uveitis–clinical/animal model • intraocular pressure

 © 2004, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. For permission to reproduce any part of this abstract, contact the ARVO Office at arvo{at}arvo.org.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH